Royal Bank of Canada
AGN

Royal Bank of Canada’s Allergan plc AGN Stock Holding History

Royal Bank of Canada’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-12,500
Closed -$2.39M – 7251
2019
Q4 		$2.39M Hold
12,500
– – ﹤0.01% 2740
2019
Q3 		$2.1M Sell
12,500
-600
-5% -$97.8K ﹤0.01% 2715
2019
Q2 		$2.19M Sell
13,100
-58,200
-82% -$8.06M ﹤0.01% 2680
2019
Q1 		$10.4M Sell
71,300
-70,900
-50% -$10.3M ﹤0.01% 1487
2018
Q4 		$19M Sell
142,200
-38,300
-21% -$6.28M 0.01% 1021
2018
Q3 		$34.4M Sell
180,500
-31,200
-15% -$5.73M 0.01% 789
2018
Q2 		$35.3M Buy
211,700
+164,200
+346% +$26.4M 0.02% 734
2018
Q1 		$7.99M Sell
47,500
-1,900
-4% -$319K ﹤0.01% 1686
2017
Q4 		$8.08M Buy
49,400
+25,000
+102% +$4.49M ﹤0.01% 1747
2017
Q3 		$5M Hold
24,400
– – ﹤0.01% 1992
2017
Q2 		$5.93M Sell
24,400
-25,000
-51% -$5.87M ﹤0.01% 1841
2017
Q1 		$11.8M Buy
49,400
+17,700
+56% +$4.12M 0.01% 1392
2016
Q4 		$6.66M Buy
31,700
+15,200
+92% +$3.15M ﹤0.01% 1763
2016
Q3 		$3.8M Sell
16,500
-45,600
-73% -$11.1M ﹤0.01% 2094
2016
Q2 		$14.4M Buy
62,100
+54,800
+751% +$12.6M 0.01% 1189
2016
Q1 		$1.96M Sell
7,300
-46,100
-86% -$13.2M ﹤0.01% 2482
2015
Q4 		$16.7M Buy
53,400
+31,800
+147% +$9.47M 0.01% 1081
2015
Q3 		$5.87M Buy
+21,600
New +$6.63M ﹤0.01% 1486

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Royal Bank of Canada's AGN Position: Q2 2020 in Review

Royal Bank of Canada sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,319,993 shares — an estimated $234M sold.

Royal Bank of Canada first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $505M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Royal Bank of Canada reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Royal Bank of Canada sold 1,319,993 Allergan plc shares in Q2 2020, an estimated $234M.
  • Royal Bank of Canada first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Royal Bank of Canada's Allergan plc position peaked at $505M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Royal Bank of Canada's 13F filing for Q2 2020, filed 14 Aug 2020.